What’s Old is New: The Past, Present and Future Role of Thalidomide in the Modern-Day Management of Multiple Myeloma Bruno Almeida CostaTarek H. MouhieddineJoshua Richter Review Article 30 June 2022 Pages: 383 - 405
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP Fatéméh DuboisCéline BazilleGuénaëlle Levallet Review Article Open access 30 July 2022 Pages: 407 - 431
Translational Modeling Predicts Efficacious Therapeutic Dosing Range of Teclistamab for Multiple Myeloma Suzette GirgisShun Xin Wang LinYusri Elsayed Original Research Article Open access 24 June 2022 Pages: 433 - 439
Pattern of Clinical Progression Until Metastatic Castration-Resistant Prostate Cancer: An Epidemiological Study from the European Prostate Cancer Registry Camille VerrySébastien VincendeauMarc-Olivier Timsit Original Research Article Open access 16 July 2022 Pages: 441 - 451
Real-World Data on Pembrolizumab for Pretreated Non-Small-Cell Lung Cancer: Clinical Outcome and Relevance of the Lung Immune Prognostic Index Ana Ortega-FrancoClare HodgsonRaffaele Califano Original Research Article 04 July 2022 Pages: 453 - 465
Real-World Treatment with Nivolumab or Cabozantinib for Metastatic Renal Cell Carcinoma (mRCC) in the Veneto Region of Italy: Results of AMOUR Study Marco MaruzzoFrancesco PierantoniVittorina Zagonel Original Research Article Open access 25 June 2022 Pages: 467 - 474
Efficacy and Safety of Immunotherapy-Based Combinations as First-Line Therapy for Metastatic Renal Cell Carcinoma in Patients Who Do Not Meet Trial Eligibility Criteria Yuki NemotoHiroki IshiharaToshio Takagi Original Research Article 05 July 2022 Pages: 475 - 482
Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer Elaine S. TanWenyi FanHao Xie Original Research Article 29 June 2022 Pages: 483 - 492
Comment on: “Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy” Yusuf Ziya ŞenerSalome Begijanashvili Letter to the Editor 11 July 2022 Pages: 493 - 494
Author’s Reply to Şener and Begijanashvili: “Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy” Iris Y. ShengAlok A. Khorana Letter to the Editor 11 July 2022 Pages: 495 - 496